November 21, 2017
BioLineRx Reports Third Quarter 2017 Financial Results
November 20, 2017
BioLineRx Announces Partial Results of BL-8040 COMBAT Study Accepted for Presentation at ASCO 2018 Gastrointestinal Cancers Symposium
November 16, 2017
BioLineRx Ltd. to Host Investor Breakfast Meeting December 5, 2017 in New York
November 9, 2017
BioLineRx to Report Third Quarter 2017 Results on November 21, 2017